Electronic Notification of Teratogenic Risks (PREVENT)
Preconception Risk Evaluation Via Electronic Medical Record Notification of Teratogenic Risks
This study will use a factorial design randomized controlled trial to (1)compare multi-faceted decision support (intervention) to streamlined clinical alerts (control) and (2) evaluate whether collecting information about women's risk of pregnancy using a networked tablet computer (intervention) is superior to the way clinicians usually collect this information (control).
Over the course of 1 year, we will abstract data from the electronic medical record when study clinicians prescribe teratogenic medications, conduct phone interviews with women prescribed medications by participating clinicians, and survey participating clinicians about their satisfaction with the decision support they receive. We will use this data to confirm our hypotheses that clinicians in the intervention groups will (1) prescribe fewer teratogenic medications, (2) be more likely to prescribe contraception when a teratogenic medication is prescribed, (3) have more patients report satisfaction with the counseling they received, and (4) report more satisfaction with the decision support they received.
研究概览
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Pennsylvania
-
Delmont、Pennsylvania、美国、15626
- Partners In Health
-
Level Green、Pennsylvania、美国、15085
- Partners In Health
-
Murrysville、Pennsylvania、美国、15085
- Partners In Health
-
Pittsburgh、Pennsylvania、美国、15213
- General Internal Medicine Oakland (GIMO) Practice
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Women aged 18-45 seen at a participating primary care clinic
Exclusion Criteria:
- Non-English speakers
学习计划
研究是如何设计的？
设计细节
- 主要用途：卫生服务研究
- 分配：随机化
- 介入模型：阶乘赋值
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：multi-faceted decision support
Multi-faceted decision support
|
multi-faceted decision support
|
|
有源比较器：control
stream-lined clinical alert
|
electronic notification that a medication is potentially teratogenic
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Proportion of women prescribed potentially teratogenic medications with documented use of contraception
大体时间：1 year
|
1 year
|
合作者和调查者
调查人员
- 首席研究员：Eleanor B Schwarz, MD, MS、University of Pittsburgh
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- R18HS017093-01 (美国 AHRQ 拨款/合同)
- 1R18HS017093-01 (美国 AHRQ 拨款/合同)
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.